Usually, after the emergence of emerging technologies, the first application area is a large machine that is large enough to occupy the entire room. It will only be applied to relatively small objects until it matures. Among them, the most typical performance is the evolution of computers in the past 70 years. Nowadays, the development of medical health has also shown this similar pattern.

At the moment, start-ups from various countries and regions around the world are seeking to transform their development capabilities. Be aware that in the past, those capabilities were limited to key laboratories with expensive large equipment, abundant capital support, and high-end technical talent. For example, in the early 20th century, in order to complete the human genome sequence, Celera Genomics used nearly 300 DNA sequencers and 7000 processors, with a capital investment of up to 100 million US dollars.

At this stage, the entire human genome can be presented and run on a common desktop machine at a cost of less than $1,000. In addition to DNA sequencing, emerging start-ups in the healthcare industry are also focusing on treatment technologies for diseases ranging from influenza to stroke. They diverted their technology, funding, and data from a handful of centralized companies to the doctors and patients who needed them most.

There is no doubt that these technologies can have a huge and far-reaching impact. Transferring medical tests from a small number of large laboratories and distributing them to households and medical centers will reduce medical costs to a large extent and help patients improve their treatment results, thus achieving the popularization of quality medical resources. Provide medical convenience for the general public. In the past, many of these large-scale equipment required high capital investment and operating costs, so many of them required installment payments.

However, thanks to the growing popularity of electronic consumer devices, the industry has successfully benefited from cost reductions. Just a decade ago, optics, microfluidics, and electronics were very expensive and rare. But now, with the help of chemical innovation and intelligent software, the cost of these tests has been reduced to some extent, and some tests are of higher quality than large peer laboratories.

In addition to the high cost of the test itself, the costs associated with hospital care have skyrocketed over the years. Many laboratories have received too many patient test samples, even beyond their testing capabilities. Additional expenses, such as hospital administration and insurance, can easily exceed the cost of the test itself. However, if the test is conducted in a small medical center or even in the patient's own home, the costs associated with the operation of the hospital can be completely avoided, thereby greatly reducing the cost of the medical diagnostic process as a whole. In addition, testing in small medical centers and patients' homes does not require waiting in line like a large laboratory, so it further improves the availability of testing and allows more people to enjoy convenient and affordable treatment. Testing service.

It has been documented that rapid and accurate diagnosis can greatly optimize their treatment for patients with multiple diseases. Because only a quick and accurate diagnosis can ensure fast and accurate treatment, avoid unnecessary hospitalization and excessive use of antibiotics. Therefore, with the help of advanced tools, the disease diagnosis time will be shortened from a few days to a few minutes, greatly improving the treatment efficiency.

In addition, tests conducted in small medical centers and in patients' homes can provide a large amount of data to equipment suppliers and patients themselves, and monitor health through continuous test data. After all, traditional diagnostics can only provide a single data point. For early disease detection, these continuous data are necessary to help patients receive correct treatment as early as possible, thereby increasing the chances of a final cure and optimizing the entire medical service process from discovery to treatment to recovery. Moreover, in the collection, analysis and response of relevant data, there are many high-quality entrepreneurial opportunities.

Of course, things have two sides. These distributed medical tests also face many challenges. First of all, the promotion and certification process requires a lot of capital investment. Secondly, the workflow of the medical center may change greatly. Finally, as a new thing, it will inevitably be involved in the fierce market competition brought by existing large companies. In addition, although these tests are small in scale and low in cost, they must also strictly comply with the regulatory standards set by the SFDA and other regulatory agencies.

Therefore, in order to truly realize the promotion and popularization of these emerging technologies, the most critical driving factor for the development is the optimization of the economies of scale of suppliers. Providing diagnostic testing services in small medical centers compared to outsourcing to large centralized laboratories requires suppliers to pay all costs independently and independently. In the past, the efficiency of telemedicine diagnostic testing has declined to a large extent because some patients do not have equipment support for specific tests at home. However, tests such as the flu that can be performed without a doctor's prescription can help telemedicine companies charge a fee for diagnosis and therapy. In this case, the supplier doesn't matter even if it is 1000 miles away. In short, all of these factors will help both the supplier and the patient to provide economies of scale.

In a word, the focus of medical testing has begun, and it is possible to improve the quality of medical care while reducing costs. In the future, it will be universal. Of course, continued capital investment and resource support are still crucial. It is hoped that entrepreneurs will seize opportunities in time to benefit the whole society and let people live longer and live healthier.

Plastic Bucket Yellow Rice Wine

Plastic Bucket Yellow Rice Wine is a type of rice wine that is fermented in a plastic bucket. It is a popular drink in many Asian countries, especially in China and Japan. The wine is made by fermenting glutinous rice with yeast and water, and then adding sugar to the mixture. The wine is then stored in a plastic bucket for several months until it is ready to be consumed. The yellow color of the wine comes from the rice used in the fermentation process. Plastic Bucket Yellow Rice Wine is typically served at room temperature and has a sweet, slightly tangy taste. It is often enjoyed with meals or as a social drink with friends and family.

Barrel Packing Yellow Rice Alcohol,Cooking Liquor,Yellow Wine for Cooking,Bucket Packing Hua Diao Liquor

Zhejiang Shengta Shaoxing Wine Co., Ltd. , https://www.shaoxingyellowricewine.com